Location History:
- Ingelheim am Rhein, DE (2023)
- Biberach, DE (2023)
Company Filing History:
2 out of 1,536 
1 out of 216 
Years Active: 2023
Title: Inventor Spotlight: Julian Wippich from Ingelheim am Rhein, DE
Introduction:
Julian Wippich, a prolific inventor hailing from Ingelheim am Rhein, DE, is known for his contributions to the field of pharmaceuticals with a focus on oncology and central nervous system diseases. With a total of 2 patents to his name, Wippich has made significant strides in the realm of innovative medical research.
Latest Patents:
1. "Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors": This patent by Julian Wippich encompasses a group of compounds that serve as inhibitors of SOS1, showcasing potential for treating and preventing oncological diseases.
2. "Substituted 3-phenoxyazetidin-1-yl-pyrazines": Another groundbreaking patent by Wippich, these compounds act as agonists of GPR52, offering promising applications in the treatment of central nervous system diseases and other related conditions.
Career Highlights:
Throughout his career, Julian Wippich has been associated with esteemed companies such as Boehringer Ingelheim International GmbH and Arena Pharmaceuticals, Inc.. His innovative work within these organizations has undoubtedly played a pivotal role in advancing pharmaceutical research and development.
Collaborations:
Wippich has had the privilege of collaborating with notable individuals in the field, including Kai Gerlach and Graeme Semple. These collaborations have fostered a spirit of innovation and knowledge-sharing, leading to the successful realization of groundbreaking inventions.
Conclusion:
Julian Wippich's dedication to pioneering research in the pharmaceutical industry is evident through his patent portfolio and influential collaborations. His commitment to developing novel compounds for the treatment of critical medical conditions underscores his invaluable contribution to the realm of innovation and inventions.